ZYMEWORKS INC. Public Float
ZYMEWORKS INC. (ZYME) had Public Float of $649.50 million as of 2025-06-30, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-02
- 2025-06-30: Entity Public Float $649.50M.
- 2024-06-30: Entity Public Float $488.10M.
- 2023-06-30: Entity Public Float $468.50M.
- 2022-06-30: Entity Public Float $306.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $649.50M 10-K · filed 2026-03-02 |
| 2024-06-30 | $488.10M 10-K · filed 2025-03-05 |
| 2023-06-30 | $468.50M 10-K · filed 2024-03-06 |
| 2022-06-30 | $306.00M 10-K/A · filed 2023-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |